RP
DGX icon

Rice Partnership’s Quest Diagnostics DGX Stock Holding History

Rice Partnership’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.31M Buy
25,040
+282
+1% +$55.3K 0.64% 39
2026
Q1 		$4.85M Buy
24,758
+234
+1% +$45.5K 0.66% 41
2025
Q4 		$4.26M Buy
24,524
+2,684
+12% +$489K 0.58% 38
2025
Q3 		$4.16M Buy
21,840
+3,288
+18% +$583K 0.59% 42
2025
Q2 		$3.33M Buy
+18,552
New +$3.22M 0.58% 41

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Rice Partnership's DGX Position: Q2 2026 in Review

Rice Partnership increased its Quest Diagnostics (DGX) stake by 1.1% in Q2 2026, buying an estimated $55.3K and bringing the position to 25,040 shares worth $5.31M. The position accounts for 0.64% of the portfolio, ranked #39.

Rice Partnership first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 461 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Rice Partnership held 25,040 shares of Quest Diagnostics worth $5.31M as of Q2 2026.
  • Rice Partnership bought 282 Quest Diagnostics shares in Q2 2026, an estimated $55.3K.
  • Quest Diagnostics made up 0.64% of Rice Partnership's portfolio in Q2 2026, its #39 holding.
  • Rice Partnership first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 461 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Rice Partnership's 13F filing for Q2 2026, filed 29 Jul 2026.